33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.91%
Net income growth under 50% of MDB's 28.62%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
26.47%
D&A growth well above MDB's 1.37%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
2.70%
SBC growth well above MDB's 2.74%. Michael Burry would flag major dilution risk vs. competitor’s approach.
82.05%
Well above MDB's 9.53% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-332.36%
AR is negative yoy while MDB is 61.05%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-285.43%
Negative yoy inventory while MDB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
203.09%
A yoy AP increase while MDB is negative at -58.26%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-4827.66%
Both reduce yoy usage, with MDB at -156.30%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-40.65%
Both negative yoy, with MDB at -167.22%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
65.15%
Operating cash flow growth at 50-75% of MDB's 87.14%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-64.60%
Negative yoy CapEx while MDB is 47.17%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5738.47%
We reduce yoy invests while MDB stands at 58.09%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-50.00%
Both yoy lines negative, with MDB at -1.40%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-101.60%
Negative yoy issuance while MDB is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.